COMMUNIQUÉS West-GlobeNewswire

Nordic Naturals Ultimate Omega Featured in New Erewhon Smoothie by J Balvin
26/06/2026
Watsonville, CA, June 26, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals , the #1 selling fish oil brand in the U.S.‡, today announced that its award-winning Ultimate Omega® is a featured ingredient in Erewhon's newly [...]
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
26/06/2026
Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that [...]
VitalHub Announces Results of Annual General Meeting of Shareholders
26/06/2026
TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on June [...]
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
26/06/2026
COPENHAGEN, Denmark, June 26, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company has been added to the broad-market Russell 3000 ® Index, the large-cap Russell 1000 ® Index, the [...]
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
26/06/2026
Webcast on Monday, June 29, 2026, at 7:45 am ET BALA CYNWYD, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing [...]
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
26/06/2026
Neuphoria Therapeutics confirms it is in talks with Scancell Holdings plc about a possible combination BURLINGTON, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) ( [...]
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance
26/06/2026
BEDMINSTER, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on June 24, 2026, it received a notice (the “Notice”) from the NYSE [...]
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
26/06/2026
WILMETTE, Ill., June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
Crescent Biopharma Announces Grants of Inducement Awards
26/06/2026
WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma
26/06/2026
SAN FRANCISCO, June 26, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the California Institute for Regenerative Medicine (CIRM) has awarded [...]
Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
26/06/2026
CHICAGO, June 26, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced a distribution agreement [...]
Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis
26/06/2026
New analyses from the Phase 3 Vivacity-MG3 study support the impact of nipocalimab in anti-AChR+ a , anti-MuSK+ b adult patients with generalised myasthenia gravis (gMG) including those early in their disease, [...]
FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health
26/06/2026
If finalized, rule would level the playing field between American and foreign businesses Silver Spring, MD, June 26, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a proposed rule that, if [...]
Board decision to file for bankruptcy
26/06/2026
Ghent, June 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION - INSIDE INFORMATION 26 June 2026, 05:15 pm CEST Ghent, Belgium, 26 June 2026 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company [...]
Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
26/06/2026
Details Strategic Actions Taken by the Board to Advance the Company’s Pipeline and Drive Value Creation Vaxart’s Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of Growth Dissident [...]
New Yorkers Celebrate Independence Through Helen Keller's Legacy at Premiere of Groundbreaking Documentary Possibilities
26/06/2026
Blind artists, educators, advocates, and creatives gather on Helen Keller's 146th birthday ahead of America's 250th anniversary NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- As America approaches the 250th anniversary of [...]
Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
26/06/2026
RESEARCH TRIANGLE PARK, N.C., June 26, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Readout from Legacy Ultimovacs DOVACC Phase II Trial Concludes UV1 Programme as Previously Guided
26/06/2026
Oslo, 26 June 2026 – Zelluna (OSE: ZLNA) , a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announces that the NSGO- [...]
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
26/06/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the expansion of its [...]

Pages